Indication

Bacteroides osteomyelitis

*Bacteroides* osteomyelitis is an uncommon, potentially destructive bone infection caused by obligate anaerobic, gram-negative bacilli of the genus *Bacteroides*, predominantly *Bacteroides fragilis*. Read more about Bacteroides osteomyelitis

56 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Bacteroides osteomyelitis therapies.

Showing 1–9 of 56 drugs

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
APACE PACKAGING

METRONIDAZOLE

NITROIMIDAZOLE ANTIBIOTICS·ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
Major Pharamceuticals

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
PLIVA, INC

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
MYLAN INSTITUTI
Filter & compare in the drug finder →Opens the drug finder with Bacteroides osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bacteroides osteomyelitis.

*Bacteroides* osteomyelitis is an uncommon, potentially destructive bone infection caused by obligate anaerobic, gram-negative bacilli of the genus *Bacteroides*, predominantly *Bacteroides fragilis*.

It most frequently involves the skeletal system via contiguous extension from adjacent soft-tissue breakdown, intra-abdominal or pelvic infections, diabetic foot ulcers, decubitus ulcers, or surgical wounds, though it may also develop through hematogenous seeding.

Pathophysiologically, the condition is characterized by suppurative inflammation, localized ischemia, progressive bone necrosis, and frequent abscess or sinus tract formation, often presenting as part of a complex, foul-smelling polymicrobial infection in adult and immunocompromised hosts.

Personalize your experience

Follow Bacteroides osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it